“Delivering innovation that supports our health systems, cancer centers, and medical practices is core to the value we bring to the clients of Ikonopedia,” said Emily Crane, president and chief executive officer of Ikonopedia. “Integrating the highly-trained CureMetrix algorithm into our MQSA management system will allow radiologists to prioritize their workflow even more efficiently, helping them manage patient flow and improve overall breast cancer detection now and into the future.”
“There has never been a better time to implement AI into radiology practices,” said, Navid Alipour, chief executive officer at CureMetrix. “CureMetrix AI can help put practices back on track quickly, and we are proud to work together with the experts at Ikonopedia to deliver solutions designed to enhance clinical confidence and improve cancer detection.”
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Both Ikonopedia and CureMetrix innovations will be featured at the virtual 2020 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting that starts November 29, 2020.
Ikonopedia was founded by three expert breast imaging Radiologists: László Tabár, MD is the author of 6 books in 10 languages on mammography and a world renowned educator; A. Thomas Stavros, MD is the author of one of the most popular reference books in the field of breast ultrasound; and Michael J. Vendrell, MD is an expert in breast MRI and CAD design with extensive experience in breast-imaging software. For more information, visit www.Ikonopedia.com
Delivering CAD that Works®, CureMetrix is a global leader in artificial intelligence (AI) for medical imaging, committed to the advancement of technology that improves cancer survival rates worldwide. CureMetrix supports the radiologist to dramatically improve the accuracy of detection and classification of anomalies in mammography. Our mission is to save lives and support better clinical and financial outcomes, visit www.CureMetrix.com Back to HCB News